TOP STORIES
Gene sequencing firm RainDance Technologies is rethinking plans to go public, at least for the time being, nearly five months after filing for a $60 million IPO.
In public filings, the 11-year-old Billerica company, which makes a unique kind of machine that can do cheaper genetic tests using just tissue and bodily fluids, said that “market conditions” caused the company to withdraw its plans. — Boston Business Journal
With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge?
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
A large clinical trial by researchers at the National Institutes of Health found that omega-3 supplements did not slow cognitive decline in older persons. With 4,000 patients followed over a five-year period, the study is one of the largest and longest of its kind.
— National Institutes of Health
LIFE SCIENCES
Medtronic has decided to purchase Twelve, a portfolio transcatheter mitral valve replacement company of medical device incubator The Foundry, for up to $458 million.
A Personalized Approach to Medication Nonadherence
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.
Mylan’s shareholders will decide in just 3 days whether the company should push forward with its pursuit of Perrigo. Apparently Perrigo is making sure its own shareholders are ready to shoot it down.
As CEO Joseph Papa wrote in a letter to investors Tuesday, Perrigo’s execs “believe deeply in our responsibility to shareholders, who are Perrigo’s true owners, and in our obligation to build sustainable, long-term value, which informs everything we do.”
PAYERS-PROVIDERS
Temple University Health System and GE Healthcare announced a pioneering, first-of-its-kind risk collaboration between a health care technology company and an academic medical center that aligns incentives to promote value by providing higher-quality radiologic imaging services more efficiently at a lower cost.
TECH
Beyond Lucid Technologies added another customer for its MEDIVIEW patient care records platform: Alameda County’s Community Paramedicine team. Alameda’s use of the platform is being helped with a grant from the California HealthCare Foundation. — PR Newswire
Dexcom has received FDA 510(k) clearance for a Bluetooth-enabled continuous glucose monitor (CGM), called the G5 Mobile CGM system.
Unlike the company’s previous connected CGM devices, the G5 Mobile CGM System has Bluetooth built right in to the transmitter and sends glucose data directly to a smartphone, so users don’t have to carry a separate receiver device. Data from the CGM can be sent to iOS devices, including the Apple Watch. Dexcom plans to launch an Android version of the app for the CGM early next year. — MobiHealth News
The Digital Health Accelerator run by the University City Science Center in Philadelphia was one of 80 accelerators around the country to receive a $50,000 award from the U.S. Small Business Administration.
—U.S. Small Business Administration
POLITICS
An explosive confrontation brewing between the House Republican leadership and conservatives over Planned Parenthood is threatening to shut down the government for the second time in three years. And House GOP leaders have yet to settle on a strategy to avert it. — Politico
On the subject of Planned Parenthood, its Gulf Coast division sought an injunction to prevent Louisiana Gov Bobby Jindal from enforcing an order that would bar Medicaid funds from going to Planned Parenthood facilities in the state beginning Sept. 2. — The Wall Street Journal
A LITTLE BIT EXTRA
According to Stephen Hawking’s new theory, there might actually be away to escape a black hole (should you ever happen to encounter one).
Photo: Flickr user Simon
